Literature DB >> 36266527

17β-neriifolin from unripe fruits of Cerbera manghas suppressed cell proliferation via the inhibition of HOXA9-dependent transcription and the induction of apoptosis in the human AML cell line THP-1.

Shohei Takase1, Young Sook Yun2, Fuki Moriya1, Saaya Sekine1, Satoshi Yotsumoto1, Katsunori Miyake3, Tadahiro Yahagi4, Akihiro Ito1, Hideshi Inoue1.   

Abstract

Homeobox A9 (HOXA9) is a transcription factor that is overexpressed in acute myeloid leukemia (AML). It is associated with the pathogenesis and progression of AML, and is a factor responsible for a poor prognosis. Therefore, the development of HOXA9-targeting molecules may contribute to not only better understanding of the mechanism of HOXA9 regulation, but also the development of therapeutic applications. We constructed a reporter assay system using the promoter region of the KBTBD10 gene, to which HOXA9 directly binds and regulates transcription, in the human acute monocytic leukemia cell line THP-1. Using this luciferase gene assay, we screened 1120 plant extracts and a methanol extract of the unripe fruits of Cerbera manghas was found to suppress the reporter gene expression mediated by the KBTBD10 promoter. From the extract, five steroid-type compounds were identified as the active constituents: 7α-neriifolin (1), 17β-neriifolin (2), 17α-digitoxigenin β-D-glucosyl-(1 → 4)-α-L-thevetoside (3), 17β-digitoxigenin β-D-glucosyl-(1 → 4)-α-L-thevetoside (4), and acetylthevetin B (5). Among the five compounds, 17β-neriifolin most potently inhibited HOXA9-dependent gene expression without affecting the HOXA9 mRNA levels, and suppressed cell proliferation by inducing apoptosis. The findings on the structure-activity relationships of the compounds from C. manghas may contribute to the development of small molecule inhibitors of HOXA9.
© 2022. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.

Entities:  

Keywords:  17β-neriifolin; Acute myeloid leukemia; HOXA9 inhibitor; Reporter gene assay; Screening

Year:  2022        PMID: 36266527     DOI: 10.1007/s11418-022-01659-6

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   3.192


  2 in total

1.  Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.

Authors:  Michiko Kano; Tomohiko Muratsubaki; Lukas Van Oudenhove; Joe Morishita; Makoto Yoshizawa; Keiji Kohno; Mao Yagihashi; Yukari Tanaka; Shunji Mugikura; Patrick Dupont; Huynh Giao Ly; Kei Takase; Motoyori Kanazawa; Shin Fukudo
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

2.  High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis.

Authors:  Ying-Yu Ma; Yuancheng Zhang; Xiao-Zhou Mou; Zheng-Chuang Liu; Guo-Qing Ru; Erguang Li
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.